Dec. 21, 2023

Ep. 41: AI for RNA Biomarker Discovery and Drug Development with Rafael Rosengarten

Ep. 41: AI for RNA Biomarker Discovery and Drug Development with Rafael Rosengarten

In this episode, VibeCast host Ray Dogum speaks with Rafael Rosengarten, PhD, CEO of Genialis, about biomarker discovery and drug development. ----------------------------------------------------------- Key Moments: 00:00:33 - Exploring Raphael's Background and Journey 00:04:50 - Favorite Guest on "Talking Precision Medicine" 00:07:02 - Joining Genialis as a Co-founder 00:10:18 - Genialis' Mission in Precision Medicine 00:12:04 - Evolution of Cancer and Predictive Biomarker Space 00:14:17 - Importance of AI in Biomarker Discovery 00:17:29 - Risks and Challenges in AI Drug Discovery 00:19:59 - Genialis's Competitive Advantage in AI Drug Discovery 00:22:48 - Genialis's Funding Journey 00:24:42 - Introduction to Responder ID 00:25:26 - Building a Supermodel 00:27:14 - Strategic Partnerships 00:28:34 - Setting Genialis Apart 00:31:36 - Genialis' Vision Guest Bio: Rafael leads Genialis’ effort to realize the promise of precision medicine, and to build a company that puts people first as a guiding principle. Prior to Genialis, he spent nearly 20 years in biomedical research, publishing on the evolution of innate immune systems, bioengineering of microbes, and genetics of development. Rafael co-invented the j5 DNA assembly design automation software for high-throughput molecular design and analyses (since commercialized by TeselaGen). Rafael earned his doctorate at Yale University, and conducted his postdoctoral research at Lawrence Berkeley National Laboratory, Joint BioEnergy Institute (JBEI) and Baylor College of Medicine. In his free time, Rafael enjoys beaches and mountains, coffee and kettlebells, and exploring the world with his wife and two children. Guest Links: Linkedin: https://www.linkedin.com/in/rrosengarten/ Genialis Linkedin: https://www.linkedin.com/company/genialis/ Genialis Website: https://www.genialis.com/ About VibeCast VibeCast is our weekly informational podcast and content series exploring the hottest topics in drug development and Web3 with some of the dynamic people that make up the Vibe community. VibeCast is a collection of long-form and short-form video content intended to help our community learn about the current opportunities and challenges in biotech fundraising and community engagement innovation. Guests include biotech founders, regulatory experts, drug development executives, blockchain technologists, web3 community builders, patient community advocates, and many other Vibe Bio community members seeking to accelerate the development of breakthrough treatments. Follow Vibe Bio's Socials: https://twitter.com/VibeBio https://www.linkedin.com/company/vibe-bio/ https://www.instagram.com/vibebiotechnology/ https://www.tiktok.com/@vibebio https://www.facebook.com/VibeBiotechnology/ Disclaimer: VibeCast is intended to be used for educational and entertainment purposes, and no information or opinions shared constitute advice or services. While guests are invited to listen, listeners acknowledge they are not being provided professional advice from the podcast or the guests. The podcast is for private non-commercial use and the statements of our guests reflect their personal views only and do not necessarily reflect the views or positions of any agency, organization, or company that they work for or are affiliated with.